https://aloxistatininhibitor.c....om/epidemiology-invo
Currently, there is no systematic evaluation of how **** and gender considerations are integrated into CPGs across Europe. This systematic review will compensate for this gap. We shall investigate the operationalization of **** and gender within European internal medicine clinical practice guidelines, and the translation of these insights into bespoke recommendations. Future ****-sensitive and
Like
Comment
Share
